Medical 21 files Form D for $20 million equity offering
The Minnesota biotechnology company has sold $550,000 of a planned $20 million round to three investors as of October 22, 2026.
SEC filing
Latest
1 story
Sign inSign in1 story
The Minnesota biotechnology company has sold $550,000 of a planned $20 million round to three investors as of October 22, 2026.
SEC filing